What is the role of clinicopathologic gene expression profiling (e.g., CP-GEP/Merlin test) in refining sentinel lymph node biopsy decision-making for primary cutaneous melanoma?

https://jamanetwork.com/journals/jamasurgery/fullarticle/2840207 https://www.mayoclinic.org/medical-professionals/surgery/news/genomic-testing-expands-options-for-melanoma-staging/mac-20591517